Approach to the Patient: Diagnosis of Cushing Syndrome
暂无分享,去创建一个
[1] L. Nieman. Molecular derangements and the diagnosis of ACTH-Dependent Cushing's syndrome. , 2021, Endocrine reviews.
[2] P. Chanson,et al. Consensus on diagnosis and management of Cushing's disease: a guideline update. , 2021, The lancet. Diabetes & endocrinology.
[3] S. Tsagarakis,et al. Inferior petrosal sinus sampling in Cushing’s syndrome: usefulness and pitfalls , 2021, Endocrine.
[4] D. Yavuz,et al. Does concomitant prolactin measurement ıncrease the accuracy of ınferior petrosal sinus sampling? , 2021, Neuroradiology.
[5] Su-jin Kim,et al. Metabolic changes in serum steroids for diagnosing and subtyping Cushing’s syndrome , 2021, The Journal of Steroid Biochemistry and Molecular Biology.
[6] A. Vaidya,et al. Assessment of mild autonomous cortisol secretion among incidentally discovered adrenal masses. , 2021, Best practice & research. Clinical endocrinology & metabolism.
[7] G. Gallia,et al. Pitfalls In Performing And Interpreting Inferior Petrosal Sinus Sampling: Personal Experience And Literature Review. , 2021, The Journal of clinical endocrinology and metabolism.
[8] A. Tabarin,et al. Hair cortisol and cortisone measurements for the diagnosis of overt and mild Cushing's syndrome. , 2021, European journal of endocrinology.
[9] B. van der Voorn,et al. Anthropometrics and Metabolic Syndrome in Relation to Glucocorticoid Receptor Polymorphisms in Corticosteroid Users , 2020, Neuroendocrinology.
[10] C. Ahuja,et al. Molecular Imaging Targeting Corticotropin Releasing Hormone Receptor for Corticotropinoma: A Changing Paradigm. , 2020, The Journal of clinical endocrinology and metabolism.
[11] E. V. van Rossum,et al. Spontaneous remission of unidentified Cushing's disease revealed by hair cortisol analysis. , 2020, The Netherlands journal of medicine.
[12] P. Chanson,et al. Non-invasive diagnostic strategy in ACTH-dependent Cushing's syndrome. , 2020, The Journal of clinical endocrinology and metabolism.
[13] V. Hasenmajer,et al. The Immune System in Cushing’s Syndrome , 2020, Trends in Endocrinology & Metabolism.
[14] A. Lacroix,et al. Adrenocortical hyperplasia: A multifaceted disease. , 2020, Best practice & research. Clinical endocrinology & metabolism.
[15] I. Bancos,et al. Cardiovascular risk and mortality in patients with active and treated hypercortisolism. , 2020, Gland surgery.
[16] C. Scaroni,et al. Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications. , 2020, Best practice & research. Clinical endocrinology & metabolism.
[17] A. Tabarin,et al. MANAGEMENT OF ENDOCRINE DISEASE: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinion. , 2020, European journal of endocrinology.
[18] C. Yedinak,et al. Hypercoagulability in Cushing Syndrome, Prevalence of Thrombotic Events: A Large, Single-Center, Retrospective Study , 2019, Journal of the Endocrine Society.
[19] Nidhi Agrawal,et al. Hormone Excess Syndromes of the Hypothalamic-Pituitary Axis , 2020 .
[20] S. Webb,et al. Quality of Life in Patients With Cushing's Disease , 2019, Front. Endocrinol..
[21] A. Stigliano,et al. Approach to patients with pseudo-Cushing’s states , 2019, Endocrine connections.
[22] O. Dekkers,et al. Improvement but no normalization of quality of life and cognitive functioning after treatment for Cushing's syndrome. , 2019, The Journal of clinical endocrinology and metabolism.
[23] J. Krabbe,et al. Retrospective analysis of repeated dexamethasone suppression tests - the added value of measuring dexamethasone. , 2019 .
[24] B. McEwen,et al. Systemic and Local Corticosteroid Use Is Associated with Reduced Executive Cognition, and Mood and Anxiety Disorders , 2019, Neuroendocrinology.
[25] F. Beuschlein,et al. Hair Glucocorticoids as a Biomarker for Endogenous Cushing’s Syndrome: Validation in Two Independent Cohorts , 2019, Neuroendocrinology.
[26] M. Rieder,et al. Hair cortisol analysis: An update on methodological considerations and clinical applications. , 2019, Clinical biochemistry.
[27] C. Stratakis,et al. Mini-review of hair cortisol concentration for evaluation of Cushing syndrome , 2018, Expert review of endocrinology & metabolism.
[28] Kevin S. Katen,et al. Glucocorticoid Receptor Mutations and Hypersensitivity to Endogenous and Exogenous Glucocorticoids , 2018, The Journal of clinical endocrinology and metabolism.
[29] T. Brue,et al. MANAGEMENT OF ENDOCRINE DISEASE: Management of Cushing's syndrome during pregnancy: solved and unsolved questions. , 2018, European journal of endocrinology.
[30] O. Franco,et al. Associations Between Systemic and Local Corticosteroid Use With Metabolic Syndrome and Body Mass Index , 2017, The Journal of clinical endocrinology and metabolism.
[31] E. V. van Rossum,et al. Scalp hair cortisol for diagnosis of Cushing's syndrome. , 2017, European journal of endocrinology.
[32] H. Raff,et al. DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome). , 2017, European journal of endocrinology.
[33] Santosh Kumar,et al. Adrenocortical carcinoma masquerading as Cushing's disease , 2017, BMJ Case Reports.
[34] A. Frigo,et al. First-line screening tests for Cushing’s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS , 2017, Journal of Endocrinological Investigation.
[35] E. Oldfield,et al. Cushing's disease: pathobiology, diagnosis, and management. , 2017, Journal of neurosurgery.
[36] A. Isidori,et al. Complications of Cushing's syndrome: state of the art. , 2016, The lancet. Diabetes & endocrinology.
[37] E. Boccardi,et al. Bilateral inferior petrosal sinus sampling , 2016, Endocrine connections.
[38] M. Bronstein,et al. Determination of nighttime salivary cortisol during pregnancy: comparison with values in non-pregnancy and Cushing’s disease , 2016, Pituitary.
[39] T. Bednarczuk,et al. The morning and late‐night salivary cortisol ranges for healthy women may be used in pregnancy , 2015, Clinical endocrinology.
[40] E. V. van Rossum,et al. Clinical applications of cortisol measurements in hair. , 2015, European journal of endocrinology.
[41] G. Noppe,et al. LC‐MS/MS‐based method for long‐term steroid profiling in human scalp hair , 2015, Clinical endocrinology.
[42] L. Nieman,et al. Cushing’s syndrome: epidemiology and developments in disease management , 2015, Clinical epidemiology.
[43] I. Chiodini,et al. Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma. , 2015, European journal of endocrinology.
[44] L. Nieman,et al. Comorbidities in Cushing’s disease , 2015, Pituitary.
[45] H. Raff,et al. Cushing's syndrome: from physiological principles to diagnosis and clinical care , 2015, The Journal of physiology.
[46] D. Dong,et al. The diagnosis and management of Cushing syndrome during pregnancy , 2015, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[47] O. Dekkers,et al. [Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis]. , 2015, Nederlands tijdschrift voor geneeskunde.
[48] B. Fève,et al. Systemic Glucocorticoid Therapy: a Review of its Metabolic and Cardiovascular Adverse Events , 2014, Drugs.
[49] R. Golfieri,et al. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. , 2014, The lancet. Diabetes & endocrinology.
[50] F. de Jong,et al. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests. , 2014, European journal of endocrinology.
[51] S. Zacharieva,et al. Mortality in Cushing's syndrome: data from 386 patients from a single tertiary referral center. , 2013, European journal of endocrinology.
[52] S. Lamberts,et al. Glucocorticoid sensitivity in health and disease , 2013, Nature Reviews Endocrinology.
[53] L. Hofland,et al. Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment , 2013, Clinical endocrinology.
[54] E. Horváth-Puhó,et al. Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. , 2013, The Journal of clinical endocrinology and metabolism.
[55] C. Dimopoulou,et al. Discriminatory value of signs and symptoms in Cushing's syndrome revisited: what has changed in 30 years? , 2013, Clinical endocrinology.
[56] F. de Jong,et al. A novel tool in the diagnosis and follow-up of (cyclic) Cushing's syndrome: measurement of long-term cortisol in scalp hair. , 2012, The Journal of clinical endocrinology and metabolism.
[57] S. Webb,et al. Clinical consequences of Cushing’s syndrome , 2012, Pituitary.
[58] E. V. van Rossum,et al. Measuring cortisol levels in hair: potential clinical applications in Cushing’s syndrome , 2012, Expert review of endocrinology & metabolism.
[59] Q. Lian,et al. Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2. , 2011, Toxicology.
[60] E. Fliers,et al. Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study. , 2011, The Journal of clinical endocrinology and metabolism.
[61] V. Montori,et al. Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline , 2011, The Journal of clinical endocrinology and metabolism.
[62] T. Sugiyama,et al. Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors. , 2011, Endocrine journal.
[63] L. Nieman,et al. Approach to the patient with an adrenal incidentaloma. , 2010, The Journal of clinical endocrinology and metabolism.
[64] G. Arnaldi,et al. Pathophysiology of Dyslipidemia in Cushing’s Syndrome , 2010, Neuroendocrinology.
[65] R. Clayton,et al. Mortality in Cushing’s Disease , 2010, Neuroendocrinology.
[66] J. Romijn,et al. Neuropsychiatric Disorders in Cushing’s Syndrome , 2010, Neuroendocrinology.
[67] M. D. De Martino,et al. Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome , 2010, Neuroendocrinology.
[68] G. Koren,et al. Hair analysis provides a historical record of cortisol levels in Cushing's syndrome. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[69] E. Fliers,et al. Hypercoagulable state in Cushing's syndrome: a systematic review. , 2009, The Journal of clinical endocrinology and metabolism.
[70] D. Huscher,et al. Dose-related patterns of glucocorticoid-induced side effects , 2008, Annals of the rheumatic diseases.
[71] V. Montori,et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.
[72] G. Chrousos,et al. Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. , 2008, The Journal of clinical endocrinology and metabolism.
[73] V. Montori,et al. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. , 2008, The Journal of clinical endocrinology and metabolism.
[74] M. D. De Martino,et al. Cushing's syndrome: aftermath of the cure. , 2007, Arquivos brasileiros de endocrinologia e metabologia.
[75] Jeffrey R Curtis,et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. , 2006, Arthritis and rheumatism.
[76] H. Russcher,et al. Strategies for the characterization of disorders in cortisol sensitivity. , 2006, The Journal of clinical endocrinology and metabolism.
[77] L. Nieman,et al. Cushing's syndrome , 2005 .
[78] M. Dallman,et al. Chronic stress and comfort foods: self-medication and abdominal obesity , 2005, Brain, Behavior, and Immunity.
[79] A. Colao,et al. The metabolic syndrome and cardiovascular risk in Cushing's syndrome. , 2005, Endocrinology and metabolism clinics of North America.
[80] J. Jonklaas,et al. Cushing's syndrome during pregnancy: personal experience and review of the literature. , 2005, The Journal of clinical endocrinology and metabolism.
[81] Frieder Keller,et al. Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids , 2005, Clinical Pharmacokinetics.
[82] H. Izzedine,et al. Antiretroviral and immunosuppressive drug-drug interactions: an update. , 2004, Kidney international.
[83] A B Atkinson,et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. , 2003, The Journal of clinical endocrinology and metabolism.
[84] A. Faggiano,et al. Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure. , 2003, The Journal of clinical endocrinology and metabolism.
[85] Khusru Asadullah,et al. Mechanisms involved in the side effects of glucocorticoids. , 2002, Pharmacology & therapeutics.
[86] C. Invitti,et al. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. , 1999, The Journal of clinical endocrinology and metabolism.
[87] C. Malchoff,et al. Glucocorticoid Resistance , 2020, Definitions.
[88] N. Shimizu. [Cushing's disease]. , 1993, Nihon rinsho. Japanese journal of clinical medicine.
[89] G. Chrousos,et al. Corticotropin-Releasing Hormone Stimulation Following Low-Dose Dexamethasone Administration: A New Test to Distinguish Cushing's Syndrome From Pseudo-Cushing's States , 1993 .
[90] R. Riddell,et al. Cushing's syndrome in pregnancy. , 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[91] D. Linch,et al. CUSHING'S SYNDROME—KILLING DISEASE: DISCRIMINATORY VALUE OF SIGNS AND SYMPTOMS AIDING EARLY DIAGNOSIS , 1982, The Lancet.
[92] A. Meikle. DEXAMETHASONE SUPPRESSION TESTS: USEFULNESS OF SIMULTANEOUS MEASUREMENT OF PLASMA CORTISOL AND DEXAMETHASONE , 1982, Clinical endocrinology.
[93] N. Shimizu. [Treatment of Cushing's disease]. , 1978, Nihon rinsho. Japanese journal of clinical medicine.